HC Wainwright Reiterates “Buy” Rating for ANI Pharmaceuticals (NASDAQ:ANIP)
ANI Pharmaceuticals (NASDAQ:ANIP – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at HC Wainwright in a research report issued on Monday,Benzinga reports. They currently have a $94.00 price target on the specialty pharmaceutical company’s stock. HC Wainwright’s price objective suggests a potential upside of 58.97% from the company’s current price. ANIP […]
ANI Pharmaceuticals (NASDAQ:ANIP – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at HC Wainwright in a research report issued on Monday,Benzinga reports. They currently have a $94.00 price target on the specialty pharmaceutical company’s stock. HC Wainwright’s price objective suggests a potential upside of 58.97% from the company’s current price. ANIP […]
